Literature DB >> 29602774

Downregulation of CD3ζ in NK Cells from Systemic Lupus Erythematosus Patients Confers a Proinflammatory Phenotype.

Abel Suárez-Fueyo1, Sean J Bradley2, Takayuki Katsuyama2, Sarah Solomon2, Eri Katsuyama2, Vasileios C Kyttaris2, Vaishali R Moulton2, George C Tsokos1.   

Abstract

Cytotoxic function and cytokine profile of NK cells are compromised in patients with systemic lupus erythematosus (SLE). CD3ζ, an important molecule for NK cell activation, is downregulated in SLE T cells and contributes to their altered function. However, little is known about the role of CD3ζ in SLE NK cells. We studied CD3ζ levels and its contribution to cytotoxic, degranulation, and cytokine production capacity of NK cells from patients with SLE. Furthermore, we studied the human NK cell line, NKL, in which manipulation of CD3ζ levels was achieved using small interfering RNA and NK cells from Rag2 mice deficient in CD3ζ. We found reduced CD3ζ expression in NK cells from SLE patients independent of disease activity. Downregulation of CD3ζ expression in NK cells is mediated, at least in part, by Caspase 3, the activity of which is higher in NK cells from patients with SLE compared with NK cells from healthy donors. CD3ζ levels correlated inversely with natural cytotoxicity and the percentage of cells capable of producing the proinflammatory cytokines IFN-γ and TNF. In contrast, CD3ζ levels showed a direct correlation with levels of Ab-dependent cellular cytotoxicity. Experiments performed in CD3ζ-silenced NKL and CD3ζ-deficient NK cells from Rag2 mice confirmed the dependence of NK cell function on CD3ζ levels. Our results demonstrate a differential role for CD3ζ in natural cytotoxicity and Ab-dependent cellular cytotoxicity. We conclude that downregulated CD3ζ confers a proinflammatory phenotype to SLE NK cells and contributes to their altered function in patients with SLE.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29602774      PMCID: PMC6048443          DOI: 10.4049/jimmunol.1700588

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

Review 1.  Systemic lupus erythematosus.

Authors:  George C Tsokos
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

2.  Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4-Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus.

Authors:  Katalin Kis-Toth; Denis Comte; Maria P Karampetsou; Vasileios C Kyttaris; Lakshmi Kannan; Cox Terhorst; George C Tsokos
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

Review 3.  Alterations in the expression of signal-transducing CD3 zeta chain in T cells from patients with chronic inflammatory/autoimmune diseases.

Authors:  Lidia Ciszak; Edyta Pawlak; Agata Kosmaczewska; Stanisław Potoczek; Irena Frydecka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-12-03       Impact factor: 4.291

Review 4.  NK cells at the interface between innate and adaptive immunity.

Authors:  A Moretta; E Marcenaro; S Parolini; G Ferlazzo; L Moretta
Journal:  Cell Death Differ       Date:  2007-06-01       Impact factor: 15.828

5.  Invariant NKT cell development requires a full complement of functional CD3 zeta immunoreceptor tyrosine-based activation motifs.

Authors:  Amy M Becker; Jon S Blevins; Farol L Tomson; Jennifer L Eitson; Jennifer J Medeiros; Felix Yarovinsky; Michael V Norgard; Nicolai S C van Oers
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

6.  Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.

Authors:  Baptiste Hervier; Vivien Beziat; Julien Haroche; Alexis Mathian; Pierre Lebon; Pascale Ghillani-Dalbin; Lucile Musset; Patrice Debré; Zahir Amoura; Vincent Vieillard
Journal:  Arthritis Rheum       Date:  2011-06

Review 7.  T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.

Authors:  Vaishali R Moulton; George C Tsokos
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

8.  Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases.

Authors:  I Puxeddu; F Bongiorni; D Chimenti; S Bombardieri; A Moretta; C Bottino; P Migliorini
Journal:  Scand J Rheumatol       Date:  2012-05-28       Impact factor: 3.641

9.  Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.

Authors:  M J Robertson; K J Cochran; C Cameron; J M Le; R Tantravahi; J Ritz
Journal:  Exp Hematol       Date:  1996-02       Impact factor: 3.084

10.  Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2.

Authors:  F De Paola; R Ridolfi; A Riccobon; E Flamini; F Barzanti; A M Granato; G L Mordenti; L Medri; P Vitali; D Amadori
Journal:  Br J Cancer       Date:  2003-01-27       Impact factor: 7.640

View more
  7 in total

1.  Preliminary results from whole-genome expression analysis in patients with secondary adrenal insufficiency treated with modified-release hydrocortisone.

Authors:  Tania Pilli; Sandro Cardinale; Silvia Cantara; Gilda Dalmazio; Raffaella Forleo; Marco Capezzone; Cristian Bassi; Massimo Negrini; Manuela Ferracin; Maria Grazia Castagna
Journal:  Endocrine       Date:  2021-01-08       Impact factor: 3.633

Review 2.  NK Cells in Autoimmune Diseases: Protective or Pathogenic?

Authors:  Meifang Liu; Shujuan Liang; Cai Zhang
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

3.  Defects at the Posttranscriptional Level Account for the Low TCRζ Chain Expression Detected in Gastric Cancer Independently of Caspase-3 Activity.

Authors:  Ana Aguinaga-Barrilero; Patricia Castro-Sánchez; Ignacio Juárez; Alberto Gutiérrez-Calvo; Noelia Rodríguez-Pérez; Adela Lopez; Remedios Gómez; José M Martin-Villa
Journal:  J Immunol Res       Date:  2020-11-28       Impact factor: 4.818

4.  Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE.

Authors:  Morgane Humbel; Florence Bellanger; Natalia Fluder; Alice Horisberger; Madeleine Suffiotti; Craig Fenwick; Camillo Ribi; Denis Comte
Journal:  Front Immunol       Date:  2021-03-22       Impact factor: 7.561

Review 5.  Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?

Authors:  Elena Gianchecchi; Domenico V Delfino; Alessandra Fierabracci
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

Review 6.  Tissue-Dependent Adaptations and Functions of Innate Lymphoid Cells.

Authors:  Julia M Murphy; Louis Ngai; Arthur Mortha; Sarah Q Crome
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

Review 7.  Cardiovascular Complications in Systemic Lupus Erythematosus.

Authors:  Rahmah Alghareeb; Afshan Hussain; Marvi V Maheshwari; Nabeeha Khalid; Pragnesh D Patel
Journal:  Cureus       Date:  2022-07-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.